Abstract

ObjectivesTo investigate the value of radiomics based on CT imaging in predicting invasive adenocarcinoma manifesting as pure ground-glass nodules (pGGNs).MethodsThis study enrolled 395 pGGNs with histopathology-confirmed benign nodules or adenocarcinoma. A total of 396 radiomic features were extracted from each labeled nodule. A Rad-score was constructed with the least absolute shrinkage and selection operator (LASSO) in the training set. Multivariate logistic regression analysis was conducted to establish the radiographic model and the combined radiographic–radiomics model. The predictive performance was validated by receiver operating characteristic (ROC) curve. Based on the multivariate logistic regression analysis, an individual prediction nomogram was developed and the clinical utility was assessed.ResultsFive radiomic features and four radiographic features were selected for predicting the invasive lesions. The combined radiographic–radiomics model (AUC 0.77; 95% CI, 0.69–0.86) performed better than the radiographic model (AUC 0.71; 95% CI, 0.62–0.81) and Rad-score (AUC 0.72; 95% CI, 0.63–0.81) in the validation set. The clinical utility of the individualized prediction nomogram developed using the Rad-score, margin, spiculation, and size was confirmed in the validation set. The decision curve analysis (DCA) indicated that using a model with Rad-score to predict the invasive lesion would be more beneficial than that without Rad-score and the clinical model.ConclusionsThe proposed radiomics-based nomogram that incorporated the Rad-score, margin, spiculation, and size may be utilized as a noninvasive biomarker for the assessment of invasive prediction in patients with pGGNs.Key Points• CT-based radiomics analysis helps invasive prediction manifested as pGGNs.• The combined radiographic–radiomics model may be utilized as a noninvasive biomarker for predicting invasive lesion for pGGNs.• Radiomics-based individual nomogram may serve as a vital decision support tool to identify invasive pGGNs, obviating further workup and blind follow-up.

Highlights

  • The improvement in the computed tomography (CT) scanners and the increasing awareness of the physical examination have led to the detection of the number of groundglass nodules (GGNs) as well as attracted unprecedented attention

  • 164 pure ground-glass nodules (pGGNs) were pathologically diagnosed as noninvasive lesions, while 231 pGGNs were invasive lesions (MIA, n = 176; invasive pulmonary adenocarcinoma (IPA), n = 55)

  • 22 pGGNs were pathologically diagnosed as noninvasive lesions, while 31 pGGNs were invasive lesions (MIA, n = 5; IPA, n = 26)

Read more

Summary

Introduction

The improvement in the computed tomography (CT) scanners and the increasing awareness of the physical examination have led to the detection of the number of groundglass nodules (GGNs) as well as attracted unprecedented attention. A majority of the international guidelines (including American College of Chest Physicians, National Comprehensive Cancer Network, and British Thoracic Society) have adopted a conservative treatment attitude for pGGNs; yet, in one study [5], 10% of pGGNs ≤ 5 mm showed growth and 1% developed into invasive lesions after 3.5 years. In other two studies [6, 7], up to 52% and 58% of pGGNs progressed during follow-up. These data indicated that many pGGNs were active and should not be neglected. It is not appropriate to utilize the same follow-up strategy or intervention for pGGNs with or without invasive components

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call